Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes-Reference-Cited by-同舟云学术

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

Published:2008-09 Issue:3 Volume:48 Page:792-798
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fracanzani Anna Ludovica,Valenti Luca,Bugianesi Elisabetta,Andreoletti Marco,Colli Agostino,Vanni Ester,Bertelli Cristina,Fatta Erika,Bignamini Daniela,Marchesini Giulio,Fargion Silvia

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.22429/fullpdf

Reference34 articles.

1. Cryptogenic cirrhosis clinical characterization and risk factors for underlying disease;Cadwell;HEPATOLOGY,1999

2. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

3. Update on nonalcoholic fatty liver disease;McCullough;J Clin Gastroenterol,2002

4. Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma;Bugianesi;Gastroenterology,2002

5. Prevalence and indicators of portal hypertension in non-alcoholic fatty liver disease;Menders;Gastroenterology,2004

Cited by 559 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial;The American Journal of Clinical Nutrition;2024-09

2. Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis;Metabolism and Target Organ Damage;2024-08-22

3. What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives;International Journal of Molecular Sciences;2024-07-15

4. Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian Individuals with Type 2 Diabetes Mellitus;Indian Journal of Endocrinology and Metabolism;2024-06-06

5. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review;Nutrition & Diabetes;2024-05-10